Welcome to Journal of Hepatocellular Carcinoma

Ahmed O Kaseb Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Hepatocellular carcinoma (HCC) develops as a consequence of underlying chronic liver disease, most commonly cirrhosis. Therefore, HCC management draws on the ex...

Full description

Bibliographic Details
Main Author: Kaseb AO
Format: Article
Language:English
Published: Dove Medical Press 2015-01-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
Online Access:https://www.dovepress.com/welcome-to-journal-of-hepatocellular-carcinoma-peer-reviewed-article-JHC
id doaj-6188b183c6ea4d7690d5e9898d61abc5
record_format Article
spelling doaj-6188b183c6ea4d7690d5e9898d61abc52020-11-25T00:42:37ZengDove Medical PressJournal of Hepatocellular Carcinoma2253-59692015-01-012015Issue 11219914Welcome to Journal of Hepatocellular CarcinomaKaseb AOAhmed O Kaseb Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Hepatocellular carcinoma (HCC) develops as a consequence of underlying chronic liver disease, most commonly cirrhosis. Therefore, HCC management draws on the expertise of a wide range of medical specialists. Currently, novel therapeutic modalities for HCC are investigated within the framework of a multidisciplinary approach. Therefore, there is a critical need for a dedicated journal for HCC with special emphasis on understanding pathogenesis, emerging diagnosis and treatment approaches, and translational research strategies.The new journal Journal of Hepatocellular Carcinoma strives to be the essential clinical guide for medical and surgical oncologists, hepatologists, interventional radiologists, and all physicians and researchers involved in the care of patients with HCC. Our journal is committed to building an intercontinental community of researchers and clinicians to encourage establishment of collaborations and development of improved strategies to advance the field and help our patients from a global prospective. HCC is a very heterogeneous disease with multiple risk factors and noted differences in natural history and treatment outcomes based on demographics, risk factors, and even geographic locations, as evident by the noted difference in the magnitude of effects and rate of adverse events based on recent clinical trials conducted on different continents using the same systemic or local therapy modality.1 Therefore, one of the ultimate goals of the journal is to advance our understanding of the biology and natural history of HCC given the differential outcome based on these variables.https://www.dovepress.com/welcome-to-journal-of-hepatocellular-carcinoma-peer-reviewed-article-JHCjournalhepatocellular carcinoma
collection DOAJ
language English
format Article
sources DOAJ
author Kaseb AO
spellingShingle Kaseb AO
Welcome to Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
journal
hepatocellular carcinoma
author_facet Kaseb AO
author_sort Kaseb AO
title Welcome to Journal of Hepatocellular Carcinoma
title_short Welcome to Journal of Hepatocellular Carcinoma
title_full Welcome to Journal of Hepatocellular Carcinoma
title_fullStr Welcome to Journal of Hepatocellular Carcinoma
title_full_unstemmed Welcome to Journal of Hepatocellular Carcinoma
title_sort welcome to journal of hepatocellular carcinoma
publisher Dove Medical Press
series Journal of Hepatocellular Carcinoma
issn 2253-5969
publishDate 2015-01-01
description Ahmed O Kaseb Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Hepatocellular carcinoma (HCC) develops as a consequence of underlying chronic liver disease, most commonly cirrhosis. Therefore, HCC management draws on the expertise of a wide range of medical specialists. Currently, novel therapeutic modalities for HCC are investigated within the framework of a multidisciplinary approach. Therefore, there is a critical need for a dedicated journal for HCC with special emphasis on understanding pathogenesis, emerging diagnosis and treatment approaches, and translational research strategies.The new journal Journal of Hepatocellular Carcinoma strives to be the essential clinical guide for medical and surgical oncologists, hepatologists, interventional radiologists, and all physicians and researchers involved in the care of patients with HCC. Our journal is committed to building an intercontinental community of researchers and clinicians to encourage establishment of collaborations and development of improved strategies to advance the field and help our patients from a global prospective. HCC is a very heterogeneous disease with multiple risk factors and noted differences in natural history and treatment outcomes based on demographics, risk factors, and even geographic locations, as evident by the noted difference in the magnitude of effects and rate of adverse events based on recent clinical trials conducted on different continents using the same systemic or local therapy modality.1 Therefore, one of the ultimate goals of the journal is to advance our understanding of the biology and natural history of HCC given the differential outcome based on these variables.
topic journal
hepatocellular carcinoma
url https://www.dovepress.com/welcome-to-journal-of-hepatocellular-carcinoma-peer-reviewed-article-JHC
work_keys_str_mv AT kasebao welcometojournalofhepatocellularcarcinoma
_version_ 1725281407929942016